Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Operating Leases (2020 - 2021)

Historic Operating Leases for Black Diamond Therapeutics (BDTX) over the last 2 years, with Q3 2021 value amounting to $29.7 million.

  • Black Diamond Therapeutics' Operating Leases rose 24169.26% to $29.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $29.7 million, marking a year-over-year increase of 24169.26%. This contributed to the annual value of $7.7 million for FY2020, which is N/A changed from last year.
  • As of Q3 2021, Black Diamond Therapeutics' Operating Leases stood at $29.7 million, which was up 24169.26% from $14.9 million recorded in Q2 2021.
  • In the past 5 years, Black Diamond Therapeutics' Operating Leases registered a high of $29.7 million during Q3 2021, and its lowest value of $388000.0 during Q2 2020.